Begin main content

Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Published on: April 6, 2015
Project Number: RA0750-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Reference List
Result type: Report

Question

  1. What is the comparative clinical effectiveness of continuous subcutaneous insulin infusion versus intermittent subcutaneous insulin injections for adults with type 1 diabetes?
  2. What is the comparative clinical effectiveness of continuous subcutaneous insulin infusion versus intermittent subcutaneous insulin injections for children with type 1 diabetes?
  3. What is the cost-effectiveness of continuous subcutaneous insulin infusion in adults versus children with type 1 diabetes?
  4. What are the evidence-based guidelines for insulin delivery in patients with type 1 diabetes?

Key Message

Two health technology assessment reports, six systematic reviews (including five meta-analyses), and seven randomized controlled trials were identified regarding the comparative clinical effectiveness of continuous subcutaneous insulin infusion versus intermittent subcutaneous insulin injections for adults or children with type 1 diabetes. Three evidence based guidelines were identified regarding insulin delivery in patients with type 1 diabetes.

Tags

diabetes mellitus, infusion pumps, insulin, insulin infusion systems, diabetes, Type 1